News
Last year, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping ...
Paris: Sanofi has announced that the European Commission has approved Sarclisa in combination with bortezomib, lenalidomide, and dexamethasone (VRd) for the induction treatment of adult ...
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which ...
The European drug authority recommends refusal of marketing authorization after study shows no benefit over placebo.
5h
Health and Me on MSNEU Approves 'Twice Yearly' Injectable HIV Drug To Fight The Virus And Stop TransmissionThe EU has approved an injectable HIV drug offering a two-month dosage schedule, marking a breakthrough in treatment ...
17h
TipRanks on MSNEurope Grants Limited Approval to Eli Lilly’s (LLY) Alzheimer’s DrugThe European Medicines Agency (EMA) has granted limited approval to Eli Lilly’s (LLY) new Alzheimer’s drug Kisunla, reversing ...
AB Science receives several European countries approval to initiate the confirmatory phase 3 study of masitinib in ALS: Paris Saturday, July 26, 2025, 18:00 Hrs [IST] AB Science S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results